| Name | membrane associated ring-CH-type finger 5 |
| Description | MARCH5 is a ubiquitin ligase of the mitochondrial outer membrane that plays a role in the control of mitochondrial morphology by regulating mitofusin-2 (MFN2; MIM 608507) and DRP1 (DNM1L; MIM 603850) (Nakamura et al., 2006 [PubMed 16936636]).[supplied by OMIM, Mar 2008] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMARCHF5 (also known as MITOL) is a mitochondria‐localized E3 ubiquitin ligase that plays a central role in governing mitochondrial dynamics and quality control. Multiple studies have demonstrated that it regulates mitochondrial morphology by modulating the activities and turnover of key fission and fusion proteins. For example, expression of MARCHF5 and its intact RING domain are required for the proper subcellular distribution and ubiquitination of regulators such as Drp1, mitofusins (MFN1 and MFN2), hFis1, and MiD49, thereby balancing mitochondrial division and fusion. In addition, defective MARCHF5 activity not only leads to elongated and interconnected mitochondrial networks or fragmentation according to cell context but also results in the accumulation of specific substrates (e.g. Mfn1 or mutant mitochondrial proteins such as misfolded SOD1 and even Polγ variants), which in turn compromise mitochondrial quality. These studies underscore a dual role of MARCHF5 in both the assembly/disassembly of mitochondrial fission complexes and the proteasome‐mediated clearance of damaged or misfolded proteins at the mitochondrial outer membrane."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "10"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its direct control of mitochondrial morphology, MARCHF5 also functions in the adaptive responses to cellular stress. Under conditions that trigger mitophagy or viral infection, MARCHF5 targets distinct substrates such as the mitophagy receptor FUNDC1, the antiviral adaptor MAVS, and even active forms of RIG-I for ubiquitin‐mediated degradation; this helps to prevent sustained or excessive signaling that could lead to cell damage. Moreover, MARCHF5’s activity at mitochondria–endoplasmic reticulum contact sites (MAMs) further modulates stress pathways by regulating IRE1α oligomerization, thereby influencing the threshold for ER stress–induced apoptosis. Finally, MARCHF5 can redistribute to peroxisomes to participate in the quality control of these organelles under stress conditions."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "11", "end_ref": "17"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to mediating mitochondrial dynamics and stress responses, MARCHF5 has emerged as an important modulator of other key cellular processes. Its activity influences apoptotic sensitivity and cell fate decisions by governing the degradation of apoptosis regulators such as the MCL1/NOXA complex, and it has been implicated in immune signaling via the TLR7 pathway. Aberrant regulation or altered expression of MARCHF5 has also been associated with oncogenic processes—as seen in ovarian and hepatocellular carcinoma—and its altered function can affect extracellular signaling (for instance, modulating MMP‐1 secretion in response to UV stress) as well as neuronal cell survival by preventing mitochondrial dysfunction induced by nitrosative stress. Such diverse roles emphasize the multifunctional nature of MARCHF5 in coordinating mitochondrial quality control with broader cellular homeostasis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "18", "end_ref": "25"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Ryo Yonashiro, Satoshi Ishido, Shinkou Kyo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A novel mitochondrial ubiquitin ligase plays a critical role in mitochondrial dynamics."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EMBO J (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.emboj.7601249"}], "href": "https://doi.org/10.1038/sj.emboj.7601249"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16874301"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16874301"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Nobuhiro Nakamura, Yasuo Kimura, Masaki Tokuda, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MARCH-V is a novel mitofusin 2- and Drp1-binding protein able to change mitochondrial morphology."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EMBO Rep (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.embor.7400790"}], "href": "https://doi.org/10.1038/sj.embor.7400790"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16936636"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16936636"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Mariusz Karbowski, Albert Neutzner, Richard J Youle "}, {"type": "b", "children": [{"type": "t", "text": "The mitochondrial E3 ubiquitin ligase MARCH5 is required for Drp1 dependent mitochondrial division."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1083/jcb.200611064"}], "href": "https://doi.org/10.1083/jcb.200611064"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17606867"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17606867"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Yong-Yea Park, Seungmin Lee, Mariusz Karbowski, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Loss of MARCH5 mitochondrial E3 ubiquitin ligase induces cellular senescence through dynamin-related protein 1 and mitofusin 1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Sci (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1242/jcs.061481"}], "href": "https://doi.org/10.1242/jcs.061481"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20103533"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20103533"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Ayumu Sugiura, Ryo Yonashiro, Toshifumi Fukuda, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A mitochondrial ubiquitin ligase MITOL controls cell toxicity of polyglutamine-expanded protein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mitochondrion (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.mito.2010.09.001"}], "href": "https://doi.org/10.1016/j.mito.2010.09.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20851218"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20851218"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Ayumu Sugiura, Shun Nagashima, Takeshi Tokuyama, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MITOL regulates endoplasmic reticulum-mitochondria contacts via Mitofusin2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molcel.2013.04.023"}], "href": "https://doi.org/10.1016/j.molcel.2013.04.023"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23727017"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23727017"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Y-Y Park, O T K Nguyen, H Kang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MARCH5-mediated quality control on acetylated Mfn1 facilitates mitochondrial homeostasis and cell survival."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cddis.2014.142"}], "href": "https://doi.org/10.1038/cddis.2014.142"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24722297"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24722297"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Shan Xu, Edward Cherok, Shweta Das, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mitochondrial E3 ubiquitin ligase MARCH5 controls mitochondrial fission and cell sensitivity to stress-induced apoptosis through regulation of MiD49 protein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Biol Cell (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1091/mbc.E15-09-0678"}], "href": "https://doi.org/10.1091/mbc.E15-09-0678"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26564796"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26564796"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Seiji Arai, Andreas Varkaris, Mannan Nouri, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MARCH5 mediates NOXA-dependent MCL1 degradation driven by kinase inhibitors and integrated stress response activation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Elife (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7554/eLife.54954"}], "href": "https://doi.org/10.7554/eLife.54954"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32484436"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32484436"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Mansoor Hussain, Aftab Mohammed, Shabnam Saifi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MITOL-dependent ubiquitylation negatively regulates the entry of PolγA into mitochondria."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS Biol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pbio.3001139"}], "href": "https://doi.org/10.1371/journal.pbio.3001139"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33657094"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33657094"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Young-Suk Yoo, Yong-Yea Park, Jae-Hoon Kim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The mitochondrial ubiquitin ligase MARCH5 resolves MAVS aggregates during antiviral signalling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncomms8910"}], "href": "https://doi.org/10.1038/ncomms8910"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26246171"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26246171"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Ziheng Chen, Lei Liu, Qi Cheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mitochondrial E3 ligase MARCH5 regulates FUNDC1 to fine-tune hypoxic mitophagy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EMBO Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.15252/embr.201643309"}], "href": "https://doi.org/10.15252/embr.201643309"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28104734"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28104734"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Keisuke Takeda, Shun Nagashima, Isshin Shiiba, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MITOL prevents ER stress-induced apoptosis by IRE1α ubiquitylation at ER-mitochondria contact sites."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EMBO J (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.15252/embj.2018100999"}], "href": "https://doi.org/10.15252/embj.2018100999"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31368599"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31368599"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Young-Suk Yoo, Yeon-Ji Park, Ho-Soo Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mitochondria ubiquitin ligase, MARCH5 resolves hepatitis B virus X protein aggregates in the liver pathogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-019-2175-z"}], "href": "https://doi.org/10.1038/s41419-019-2175-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31819032"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31819032"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Yeon-Ji Park, Nguyen Thi Kim Oanh, June Heo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dual targeting of RIG-I and MAVS by MARCH5 mitochondria ubiquitin ligase in innate immunity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Signal (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cellsig.2019.109520"}], "href": "https://doi.org/10.1016/j.cellsig.2019.109520"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31881323"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31881323"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Jun Zheng, Xi Chen, Qiang Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ubiquitin ligase MARCH5 localizes to peroxisomes to regulate pexophagy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biol (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1083/jcb.202103156"}], "href": "https://doi.org/10.1083/jcb.202103156"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34747980"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34747980"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Rui Liu, Lin-Wen Zeng, Hui-Fang Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PD-1 signaling negatively regulates the common cytokine receptor γ chain via MARCH5-mediated ubiquitination and degradation to suppress anti-tumor immunity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Res (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41422-023-00890-4"}], "href": "https://doi.org/10.1038/s41422-023-00890-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37932447"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37932447"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Ryo Yonashiro, Ayumu Sugiura, Misako Miyachi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mitochondrial ubiquitin ligase MITOL ubiquitinates mutant SOD1 and attenuates mutant SOD1-induced reactive oxygen species generation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Biol Cell (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1091/mbc.e09-02-0112"}], "href": "https://doi.org/10.1091/mbc.e09-02-0112"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19741096"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19741096"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "He-Xin Shi, Xing Liu, Qiang Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mitochondrial ubiquitin ligase MARCH5 promotes TLR7 signaling by attenuating TANK action."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS Pathog (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.ppat.1002057"}], "href": "https://doi.org/10.1371/journal.ppat.1002057"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21625535"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21625535"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Ryo Yonashiro, Yuya Kimijima, Takuya Shimura, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mitochondrial ubiquitin ligase MITOL blocks S-nitrosylated MAP1B-light chain 1-mediated mitochondrial dysfunction and neuronal cell death."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1114985109"}], "href": "https://doi.org/10.1073/pnas.1114985109"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22308378"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22308378"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Jianguo Hu, Ying Meng, Zhanqin Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MARCH5 RNA promotes autophagy, migration, and invasion of ovarian cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Autophagy (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/15548627.2016.1256520"}], "href": "https://doi.org/10.1080/15548627.2016.1256520"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27875077"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27875077"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Manuel D Haschka, Gerlinde Karbon, Claudia Soratroi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MARCH5-dependent degradation of MCL1/NOXA complexes defines susceptibility to antimitotic drug treatment."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Differ (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41418-020-0503-6"}], "href": "https://doi.org/10.1038/s41418-020-0503-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32015503"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32015503"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Tirta Mario Djajawi, Lei Liu, Jia-Nan Gong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MARCH5 requires MTCH2 to coordinate proteasomal turnover of the MCL1:NOXA complex."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Differ (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41418-020-0517-0"}], "href": "https://doi.org/10.1038/s41418-020-0517-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32094511"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32094511"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Yushi Katsuyama, Yuri Okano, Hitoshi Masaki "}, {"type": "b", "children": [{"type": "t", "text": "A decrease of mitochondrial ubiquitin ligase increases the secretion of matrix metalloproteinase-1 by dermal fibroblasts through the induction of ER stress."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Photodermatol Photoimmunol Photomed (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/phpp.12897"}], "href": "https://doi.org/10.1111/phpp.12897"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37337400"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37337400"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Xin Cai, Jie Gao, Zhiping Yan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MARCH5 promotes hepatocellular carcinoma progression by inducing p53 ubiquitination degradation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cancer Res Clin Oncol (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00432-024-05782-7"}], "href": "https://doi.org/10.1007/s00432-024-05782-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38861187"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38861187"}]}]}]}
|
| NCBI Gene ID | 54708 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MARCHF5 has 2,179 functional associations with biological entities spanning 6 categories (chemical, functional term, phrase or reference, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 39 datasets.
Click the + buttons to view associations for MARCHF5 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of MARCHF5 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of MARCHF5 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with MARCHF5 protein from the CCLE Cell Line Proteomics dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of MARCHF5 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of MARCHF5 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing MARCHF5 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with MARCHF5 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of MARCHF5 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with MARCHF5 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with MARCHF5 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving MARCHF5 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving MARCHF5 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing MARCHF5 protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing MARCHF5 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by MARCHF5 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by MARCHF5 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of MARCHF5 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of MARCHF5 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of MARCHF5 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by MARCHF5 gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of MARCHF5 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of MARCHF5 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| KEGG Pathways 2026 | pathways involving MARCHF5 protein from the KEGG Pathways 2026 dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of MARCHF5 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of MARCHF5 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by MARCHF5 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of MARCHF5 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving MARCHF5 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of MARCHF5 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of MARCHF5 gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of MARCHF5 gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of MARCHF5 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of MARCHF5 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of MARCHF5 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of MARCHF5 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of MARCHF5 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of MARCHF5 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of MARCHF5 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with MARCHF5 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |